Envista’s (NVST) Hold Rating Reaffirmed at Needham & Company LLC

Envista (NYSE:NVST)‘s stock had its “hold” rating reaffirmed by research analysts at Needham & Company LLC in a research note issued to investors on Friday, Marketbeat.com reports.

A number of other equities analysts have also commented on the stock. BMO Capital Markets restated a “market perform” rating on shares of Envista in a research report on Thursday, September 10th. Mizuho set a $29.00 target price on shares of Envista in a report on Thursday, August 6th. Robert W. Baird set a $34.00 price target on shares of Envista in a report on Thursday, August 6th. Deutsche Bank Aktiengesellschaft set a $32.00 price target on shares of Envista in a report on Thursday, September 3rd. Finally, Morgan Stanley set a $23.00 price target on shares of Envista in a research report on Thursday, August 6th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat, Envista currently has a consensus rating of “Moderate Buy” and an average target price of $29.71.

Envista Price Performance

Shares of NYSE NVST opened at $23.72 on Friday. The stock has a market cap of $3.81 billion, a PE ratio of 40.90, a price-to-earnings-growth ratio of 1.19 and a beta of 0.86. Envista has a fifty-two week low of $18.77 and a fifty-two week high of $30.42. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.07 and a current ratio of 2.43. The stock has a fifty day moving average of $27.01 and a 200-day moving average of $26.06.

Envista (NYSE:NVST) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.34 by $0.07. The business had revenue of $730.50 million for the quarter, compared to analysts’ expectations of $716.11 million. Envista had a return on equity of 7.88% and a net margin of 3.33%.The firm’s quarterly revenue was up 7.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.26 EPS. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. Equities research analysts anticipate that Envista will post 1.53 earnings per share for the current year.

Insider Buying and Selling at Envista

In other news, SVP Mischa Reis sold 8,000 shares of the company’s stock in a transaction on Thursday, August 20th. The shares were sold at an average price of $27.50, for a total value of $220,000.00. Following the completion of the sale, the senior vice president owned 27,321 shares of the company’s stock, valued at approximately $751,327.50. This represents a 22.65% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.99% of the company’s stock.

Hedge Funds Weigh In On Envista

Large investors have recently added to or reduced their stakes in the business. Arrowstreet Capital Limited Partnership lifted its stake in Envista by 341.5% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,858,293 shares of the company’s stock worth $72,515,000 after purchasing an additional 2,210,847 shares during the last quarter. Norges Bank purchased a new stake in Envista during the fourth quarter valued at about $45,113,000. Wellington Management Group LLP grew its stake in shares of Envista by 2,662.1% during the second quarter. Wellington Management Group LLP now owns 1,686,415 shares of the company’s stock valued at $44,437,000 after buying an additional 1,625,360 shares during the last quarter. Bank of New York Mellon Corp bought a new position in shares of Envista during the second quarter valued at about $37,316,000. Finally, Pzena Investment Management LLC purchased a new position in shares of Envista in the second quarter worth about $30,494,000.

About Envista

Envista Holdings Corporation is a global dental products and technologies company headquartered in Brea, California. The company develops, manufactures and markets products used by dentists, dental specialists, dental laboratories and other oral-care professionals.

Envista’s portfolio includes dental imaging and diagnostic systems, digital dentistry and CAD/CAM solutions, dental implants, orthodontic brackets and wires, clear aligner products, endodontic instruments, restorative materials, infection-prevention products and other dental consumables.